FDA plans Virtual Town Hall on COVID-19 testing
March 20, 2020
On Wednesday, March 25, 2020, from 3 pm – 4 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2 and the recently issued guidance.
Background: On March 16, 2020, the FDA issued an updated policy on COVID-19 Diagnostics: Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.
More info here.